PMFA
HALO icon

Plante Moran Financial Advisors’s Halozyme HALO Stock Holding History

Plante Moran Financial Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78 Buy
+1
New +$68 ﹤0.01% 1560
2017
Q1 		– Sell
-118
Closed -$1K – 934
2016
Q4 		$1K Buy
118
+28
+31% +$307 ﹤0.01% 914
2016
Q3 		$1K Hold
90
– – ﹤0.01% 890
2016
Q2 		$1K Hold
90
– – ﹤0.01% 859
2016
Q1 		$1K Buy
+90
New +$847 ﹤0.01% 804

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Plante Moran Financial Advisors's HALO Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Halozyme (HALO) in Q2 2026: 1 share worth $78. The stake represents ﹤0.01% of the portfolio and ranks #1560 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in HALO as recently as Q4 2016.

Plante Moran Financial Advisors first reported a position in HALO in Q1 2016 and has held it in 5 quarters since. The position peaked at $1K in Q4 2016. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Plante Moran Financial Advisors held 1 share of Halozyme worth $78 as of Q2 2026.
  • Halozyme was a new Plante Moran Financial Advisors position in Q2 2026.
  • Halozyme made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1560 holding.
  • Plante Moran Financial Advisors first reported a position in Halozyme in Q1 2016 and has held it in 5 quarters since.
  • Plante Moran Financial Advisors's Halozyme position peaked at $1K in Q4 2016.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.